Status:
RECRUITING
Identification of Novel Biomarkers to Aid in the Detection of Occult Cancer in Patients With Venous Thromboembolism
Lead Sponsor:
Danderyd Hospital
Collaborating Sponsors:
Karolinska Institutet
Conditions:
Cancer
Venous Thromboembolism
Eligibility:
All Genders
18+ years
Brief Summary
Venous thromboembolism is a common and serious complication in cancer, and is associated with a substantially increased morbidity and mortality. Furthermore, VTE may be the earliest sign of cancer. Re...
Eligibility Criteria
Inclusion
- Venous thromboembolism (thrombosis in the deep venous system of upper or lower extremities or iliac veins and/or pulmonary embolism) as detected by ultrasonography, phlebography, computer tomography, or angiography;
- \> 18 years or older;
- Written informed consent
Exclusion
- \> 2 days after VTE diagnosis;
- No blood withdrawal at baseline
Key Trial Info
Start Date :
March 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03781531
Start Date
March 1 2017
End Date
December 31 2028
Last Update
December 20 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Danderyd Hospital
Stockholm, Sweden, 18350
2
Södersjukhuset
Stockholm, Sweden